ampicillin has been researched along with norfloxacin in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (8.93) | 18.7374 |
| 1990's | 10 (8.93) | 18.2507 |
| 2000's | 27 (24.11) | 29.6817 |
| 2010's | 56 (50.00) | 24.3611 |
| 2020's | 9 (8.04) | 2.80 |
| Authors | Studies |
|---|---|
| Batra, S; Kumar, M; Nag, S; Pathak, R; Shukla, PK | 1 |
| Levy, SB; Nicoloff, H; Perreten, V | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Li, Y; Zhang, Y | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Jones, GL; Stickler, DJ | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Wang, X; Zhao, X | 1 |
| Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
| Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
| Mali, MD; Patel, MM; Patel, SK | 1 |
| Dhamdhere, G; Krishnamoorthy, G; Zgurskaya, HI | 1 |
| Makawana, JA; Mungra, DC; Patel, MP; Patel, RG | 1 |
| Akhaja, TN; Raval, JP | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Patel, MP; Patel, RG; Shah, NM | 1 |
| Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
| Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
| Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S | 1 |
| Kathrotiya, HG; Patel, MP | 1 |
| Kanawade, SB; Rajani, DP; Toche, RB | 1 |
| Jardosh, HH; Patel, MP | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Bouillon, A; Cresteil, T; Fontaine, F; Héquet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
| Chaudhary, AS; Cui, J; Damera, K; Hsieh, YH; Jin, J; Tai, PC; Wang, B; Yang, H; Zhang, H | 1 |
| Athar, M; Jain, VK; Jha, PC; Mehta, V; Modi, K; Panchal, M | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gruber, JD; Pachaiyappan, B; Schmidt, MG; Wang, B; Woster, PM; Zhang, YM | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Kamani, RD; Karad, SC; Purohit, VB; Raval, DK; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P; Thummar, RP; Vaghasiya, BK | 1 |
| Sankar, C; Umamatheswari, S | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
| Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
| Bai, L; Deng, J; Feng, L; Lv, Z; Wang, Y; Xu, Z; Zhang, F; Zhao, S | 1 |
| Bukhari, SNA; Mallesha, N; Manukumar, HM; Qin, HL; Rakesh, KP; Vivek, HK; Wang, SM; Zha, GF | 1 |
| Guo, H | 1 |
| Zhang, B | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Hannan, A | 1 |
| Kaatz, GW; Ruble, CA; Seo, SM | 1 |
| Faegri, A; Melby, K | 1 |
| Deligianis, V; Filippidis, I; Georgoulias, N; Iatrakis, G; Kourounis, G; Louvrou, N | 1 |
| Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
| Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
| Berrocal, CI; Berrocal, L; Pérez, JL; Riera, L; Valls, F | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Dalton, H; Evans, T; Gruninger, RP; Kaplowitz, LG; Simpson, M; Vartivarian, S; Vishniavsky, N | 1 |
| Martin, E; Nauciel, C | 1 |
| Caccamo, F; Nicoletti, G; Nicolosi, VM; Speciale, A; Stefani, S | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Aguilar, L; Fernández-Roblas, R; García-Corbeira, P; López, JC; Soriano, F | 1 |
| Ishiguro, EE; Rodionov, DG | 1 |
| Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
| Chen, CH; Chiang, HY; Lee, F; Lee, JH; Lee, SH; Liu, YT; Tsou, TL; Wang, TM | 1 |
| Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
| Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
| Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Araj, GF; Zouain, MG | 1 |
| Chuma, T; Ikeda, T; Maeda, T; Niwa, H; Okamoto, K | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Bittner, A; Lerner, D; Liu, X; Miller, N; Morrow, BJ; Shaw, KJ; Wan, J | 1 |
| Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
| Dastych, M; Díte, P; Husová, L; Juránková, J; Lata, J; Príbramská, V; Senkyrík, M | 1 |
| Dastych, M; Díte, P; Husová, L; Juránková, J; Kroupa, R; Lata, J; Príbramská, V; Senkyrík, M | 1 |
| Chiung, YM; Han, JM; Lai, HL; Lin, WP; Liu, YL; Liu, YT; Shiau, CY; Yang, CM | 1 |
| Wright, GD | 1 |
| Collins, JJ; Dwyer, DJ; Hayete, B; Kohanski, MA; Lawrence, CA | 1 |
| Bibiloni, R; Blancher, F; Burcelin, RG; Cani, PD; Chou, CJ; Corthesy, I; Jaquet, M; Macé, K; Membrez, M | 1 |
| Blancher, F; Chou, CJ; Membrez, M | 1 |
| Jõers, A; Kaldalu, N; Tenson, T | 1 |
| Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
| Collins, JJ; Devadoss, B; Foti, JJ; Walker, GC; Winkler, JA | 1 |
| Callura, JM; Camacho, DM; Collins, JJ; Dwyer, DJ; Kohanski, MA | 1 |
| Imlay, JA; Liu, Y | 1 |
| Joung, DK; Kang, OH; Kim, SB; Kim, YC; Kim, YS; Kweon, KT; Kwon, DY; Lee, DS; Mun, SH; Seo, YS; Shin, DW | 1 |
| Jenal, U; Keck, W; Renggli, S; Ritz, D | 1 |
| Dance, DAB; Dow, S; Goodyear, A; Rholl, DA; Schweizer, HP; Silisouk, J; Strange, L | 1 |
| Han, J; He, L; Shi, W; Wang, S; Xu, X; Zhang, S; Zhang, Y | 1 |
| Kogermann, K; Lippus, M; Lukk, E; Putrinš, M; Tenson, T; Varik, V | 1 |
| Belenky, P; Cohen, NR; Collins, JJ; Ferrante, T; Jain, S; Korry, BJ; Lobritz, MA; Porter, CB; Schwarz, EG; Walker, GC; Ye, JD | 1 |
| Cho, DH; Heo, P; Jin, YS; Jung, SC; Kim, JS; Kim, PJ; Kweon, DH; Lee, CH; Lee, DH; Lee, S; Lee, SC; Oh, EJ; Park, M; Shin, D; Sung, J | 1 |
| Ahn, J; Ding, T; Jo, A; Kim, J; Lee, HY | 1 |
| Akutagawa, M; Emoto, T; Harada, Y; Hou, Y; Kinouchi, Y; Mawatari, K; Nakahashi, M; Shimohata, T; Takahashi, A; Tsunedomi, A; Uebanso, T | 1 |
| Guo, P; Tian, Y; Wu, C; Yu, J; Zhang, R; Zhang, X | 1 |
| Aderibigbe, BA; Fonkui, YT; Kumar, P; Ndinteh, DT; Ngece, K | 1 |
| Abebe, N; Ahmed, M; Awol, N; Bsrat, A; Gugsa, G; Hagos, Y; Tsegaye, Y | 1 |
| de Oliveira, MR; Dos Santos, HS; Douglas Melo Coutinho, H; Emidio Sampaio Nogueira, C; Esmeraldo Rocha, J; Hemília de Souza Nunes, P; Luiz Silva Pereira, R; Machado Marinho, E; Machado Marinho, M; Magno Rodrigues Teixeira, A; Nogueira Bandeira, P; Sampaio de Freitas, T; Santos Oliveira, L; Silva Marinho, E; Sousa Aquino, S | 1 |
| Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR | 1 |
| Araújo, NJS; Coutinho, HDM; da Silva, ARP; de Freitas, TS; de Sousa, EO; de Vasconcelos, JEL; do Socorro Costa, M; Filho, JMB; Maia, FPA; Pereira Junior, FN; Pinheiro, JCA; Tavares, JF | 1 |
9 review(s) available for ampicillin and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Benzofurans; Humans; Structure-Activity Relationship | 2019 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Blood Glucose; Cecum; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Insulin; Lipid Metabolism; Liver; Mice; Mice, Obese; Norfloxacin; Obesity | 2008 |
3 trial(s) available for ampicillin and norfloxacin
| Article | Year |
|---|---|
Norfloxacin in the treatment of uncomplicated gonococcal infections.
Topics: Adult; Aged; Ampicillin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Middle Aged; Norfloxacin; Probenecid; Random Allocation | 1987 |
[Factors participating in development of bleeding varices in portal hypertension. Part I: bacterial infection and comparison of intravenous and peroral antibiotics effects--a randomised study].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Sulbactam | 2004 |
Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics--a randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Injections, Intravenous; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Sulbactam; Treatment Outcome | 2005 |
100 other study(ies) available for ampicillin and norfloxacin
| Article | Year |
|---|---|
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
Topics: Acetates; Allylamine; Anti-Bacterial Agents; Cyclization; Gram-Negative Bacteria; Gram-Positive Bacteria; Isocyanates; Isothiocyanates; Microbial Sensitivity Tests; Thiourea; Urea | 2006 |
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Amplification; Genome, Bacterial; Genomic Instability; Multidrug Resistance-Associated Proteins; Mutation; Protease La | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Culture Media; Drug Tolerance; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Heat-Shock Response; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Transcription Factors | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Contribution of oxidative damage to antimicrobial lethality.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; Catalase; Escherichia coli; Escherichia coli Proteins; Hydroxyl Radical; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Superoxide Dismutase; Thiourea | 2009 |
First detection of plasmid-encoded blaOXY beta-lactamase.
Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives.
Topics: Acridines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus niger; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2010 |
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Erythromycin; Escherichia coli; Glutathione; Kanamycin; Microbial Sensitivity Tests; Novobiocin; Spermidine | 2010 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microwaves; Mycoses; Pyrans; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazines; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Boronic Acids; Ciprofloxacin; Humans; KB Cells; Multidrug Resistance-Associated Proteins; Pyridines; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Binding Sites; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kinetics; Light; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidation-Reduction; Protein Structure, Tertiary; Rose Bengal; SEC Translocation Channels; SecA Proteins; Staphylococcus aureus | 2015 |
Efficiently functionalized oxacalix[4]arenes: Synthesis, characterization and exploration of their biological profile as novel HDAC inhibitors.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Binding Sites; Calixarenes; Cell Line, Tumor; Cell Survival; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary | 2016 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Antibacterial Diamines Targeting Bacterial Membranes.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cell Membrane Permeability; Chemistry Techniques, Synthetic; Diamines; Drug Evaluation, Preclinical; Drug Interactions; Escherichia coli; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs.
Topics: Anti-Infective Agents; Bacteria; Bacterial Proteins; Catalytic Domain; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2017 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
Topics: Bacterial Infections; Biofilms; Drug Resistance, Multiple; Electron Transport Chain Complex Proteins; Fluorides; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Oxidation-Reduction; Staphylococcal Infections; Sulfinic Acids; Sulfones | 2019 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Mechanisms of fluoroquinolone resistance in Staphylococcus aureus.
Topics: Ampicillin; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Cloning, Molecular; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Humans; Membrane Proteins; Mutation; Norfloxacin; Nucleic Acid Hybridization; R Factors; Restriction Mapping; Staphylococcus aureus | 1991 |
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Topics: Ampicillin; Ampicillin Resistance; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Penicillin Resistance | 1989 |
[Treatment of urinary infections in pregnant women].
Topics: Ampicillin; Female; Humans; Norfloxacin; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis | 1989 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin | 1987 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Norfloxacin; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium | 1987 |
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperacillin | 1987 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter jejuni; Colistin; Digestive System; Doxycycline; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrionaceae | 1994 |
Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli.
Topics: Ampicillin; Ampicillin Resistance; Cerulenin; Chloramphenicol; Enzyme Inhibitors; Escherichia coli; Glycerol; Guanosine Tetraphosphate; Norfloxacin; Penicillins; Peptidoglycan; Phospholipids; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Drug Resistance, Microbial; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Pseudomonas aeruginosa; Pyocins | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cecum; Chickens; Drug Resistance, Microbial; Erythromycin; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Penicillins; Poultry Diseases; Tetracycline | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents.
Topics: Ampicillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Gene Expression; Gene Expression Profiling; Kanamycin; Microbial Sensitivity Tests; Norfloxacin; Oligonucleotide Array Sequence Analysis; Rifampin; Transcription, Genetic | 2003 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
Effect of melanin produced by a recombinant Escherichia coli on antibacterial activity of antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Kanamycin; Melanins; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Plasmids; Polymyxin B; Recombinant Proteins; Spectrum Analysis; Tetracycline | 2005 |
On the road to bacterial cell death.
Topics: Ampicillin; Anti-Bacterial Agents; Carbon-Sulfur Lyases; Cell Death; Citric Acid Cycle; DNA Damage; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Ferrous Compounds; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Hydroxyl Radical; Kanamycin; Membrane Proteins; Microbial Viability; Mutation; NAD; Norfloxacin; Oxidative Stress; Rec A Recombinases; Staphylococcus aureus; Time Factors | 2007 |
A common mechanism of cellular death induced by bactericidal antibiotics.
Topics: 2,2'-Dipyridyl; Ampicillin; Anti-Bacterial Agents; Carbon-Sulfur Lyases; Cell Death; Citric Acid Cycle; Colony Count, Microbial; DNA Damage; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Ferrous Compounds; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Hydroxyl Radical; Hydroxyurea; Iron Chelating Agents; Kanamycin; Membrane Proteins; Microbial Viability; Mutation; NAD; Norfloxacin; Oxidative Stress; Rec A Recombinases; Staphylococcus aureus; Time Factors | 2007 |
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Bifidobacterium; Diabetes Mellitus, Type 2; Enterobacteriaceae; Lactobacillus; Mice; Mice, Obese; Microbial Sensitivity Tests; Norfloxacin; Obesity | 2008 |
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Norfloxacin | 2010 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Deoxyguanine Nucleotides; DNA Breaks, Double-Stranded; DNA Glycosylases; DNA Polymerase beta; DNA Polymerase I; DNA Polymerase II; DNA-Directed DNA Polymerase; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Guanine; Guanine Nucleotides; Hydroxyl Radical; Kanamycin; Microbial Viability; Models, Biological; Norfloxacin; Oxidation-Reduction; Pyrophosphatases; RNA, Bacterial | 2012 |
Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis.
Topics: Ampicillin; Anti-Bacterial Agents; Apoptosis; Bacterial Proteins; Caspases; Chromosomes, Bacterial; DNA Fragmentation; Endopeptidase Clp; Escherichia coli; Escherichia coli Proteins; Gentamicins; In Situ Nick-End Labeling; Norfloxacin; Phosphatidylserines; Rec A Recombinases; SOS Response, Genetics; Stress, Physiological; Substrate Specificity | 2012 |
Cell death from antibiotics without the involvement of reactive oxygen species.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; DNA Repair; DNA Replication; Drug Resistance, Bacterial; Escherichia coli; Hydrogen Peroxide; Iron; Kanamycin; Norfloxacin; Oxidative Stress; Protein Biosynthesis; Reactive Oxygen Species | 2013 |
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Curcuma; Curcumin; Drug Synergism; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Plant Extracts; Rhizome; Time Factors | 2013 |
Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Escherichia coli; Flow Cytometry; Fluorescence; Fluorescent Dyes; Hydroxyl Radical; Microbial Sensitivity Tests; Mutation; Norfloxacin; Reactive Oxygen Species | 2013 |
An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Burkholderia pseudomallei; Culture Media; Feces; Female; Humans; Melioidosis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Norfloxacin; Polymyxin B; Sensitivity and Specificity | 2013 |
Glycerol uptake is important for L-form formation and persistence in Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Gene Library; Glycerol; Mutagenesis, Insertional; Norfloxacin; Staphylococcus aureus | 2014 |
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Complement C3; Drug Resistance, Bacterial; Genetic Heterogeneity; Genotype; Humans; Microbial Sensitivity Tests; Microscopy, Fluorescence; Norfloxacin; Phenotype; Uropathogenic Escherichia coli | 2015 |
Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage.
Topics: Ampicillin; Anti-Bacterial Agents; DNA Breaks, Double-Stranded; Escherichia coli; Kanamycin; Norfloxacin; Oxidative Stress | 2015 |
Fumarate-Mediated Persistence of Escherichia coli against Antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Citric Acid Cycle; Drug Resistance, Multiple, Bacterial; Electron Transport; Escherichia coli; Fumarates; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Library; Kanamycin; Microbial Sensitivity Tests; Norfloxacin; Operon; Succinate Dehydrogenase | 2016 |
Assessment of altered binding specificity of bacteriophage for ciprofloxacin-induced antibiotic-resistant Salmonella Typhimurium.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteriophages; beta-Lactamases; Binding Sites; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Norfloxacin; Salmonella typhimurium; Tetracycline; Trans-Activators | 2016 |
Combined treatment of UVA irradiation and antibiotics induces greater bactericidal effects on Vibrio parahaemolyticus.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Disinfection; Gentamicins; Humans; Norfloxacin; Ultraviolet Rays; Vibrio parahaemolyticus | 2016 |
The pandanus tectorius fruit extract (PTF) modulates the gut microbiota and exerts anti-hyperlipidaemic effects.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroidetes; Blood Glucose; Body Weight; Diet, High-Fat; Feces; Fruit; Gastrointestinal Microbiome; Humans; Hyperlipidemias; Lactobacillus; Male; Mice; Mice, Inbred C57BL; Norfloxacin; Pandanaceae; Plant Extracts; Plants, Medicinal; Polyphenols | 2019 |
Alginate-gum acacia based sponges as potential wound dressings for exuding and bleeding wounds.
Topics: Acrylic Resins; Alginates; Ampicillin; Anti-Bacterial Agents; Bandages; Blood Coagulation; Calcium Chloride; Freeze Drying; Gum Arabic; Humans; Microbial Sensitivity Tests; Norfloxacin; Porosity; Proteus vulgaris; Staphylococcus aureus; Staphylococcus epidermidis | 2021 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Chloramphenicol; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Goats; Meat; Microbial Sensitivity Tests; Norfloxacin; Prevalence; Streptomycin; Sulfamethoxazole; Trimethoprim | 2021 |
Potentiation of antibiotic activity, and efflux pumps inhibition by (2E)-1-(4-aminophenyl)-3-(4-fluorophenyl)prop-2-en-1-one.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Chlorpromazine; Escherichia coli; Fluorine; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Staphylococcus aureus; Symporters | 2022 |
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic
Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors | 2022 |
Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Diosgenin; Escherichia coli; Ethidium; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Saponins; Staphylococcal Infections; Staphylococcus aureus | 2022 |